Cigna Group, US1255231003

The Cigna Group stock slips 0.85% below Monday's Xetra close

Published on 11/17/2026 at 15:45 | Editorial responsibility: Rafael Müller, Editor-in-Chief AD HOC NEWS
The Cigna Group stock traded at 269.70 euros on Lang & Schwarz on Tuesday afternoon. Its latest quarter lifted the outlook while pharmacy risks remained visible.

Earnings context remains mixed

  • The Cigna Group raised its 2026 adjusted earnings outlook after third-quarter revenue rose 6 percent.
  • Pharmacy Benefit Services earnings fell, while Cigna Healthcare delivered stronger operating results.
Cigna Group, US1255231003, Illustration mit AI erstellt.

The Cigna Group stock traded at 269.70 euros on Lang & Schwarz at 15:35 CET on Tuesday, November 17, 2026, 0.85 percent below the Xetra close of 272.00 euros on Monday, November 16. The move also leaves the shares 1.21 percent below the 273.00-euro level cited in the previous report on November 16.

Quarterly growth supported guidance

In results released on November 5, The Cigna Group reported third-quarter revenue of 73.7 billion US dollars, up 6 percent from the year-earlier period. Adjusted income from operations reached 2.1 billion US dollars, or 7.98 US dollars per share, compared with 7.83 US dollars a year earlier, according to the Financial Times company announcement.

Management raised its full-year 2026 adjusted income-from-operations outlook to at least 30.60 US dollars per share from at least 30.45 US dollars. The outlook also calls for at least 4.6 billion US dollars in pre-tax adjusted income from operations at Cigna Healthcare, while the Evernorth target remained at least 6.9 billion US dollars.

Pharmacy pressure offsets strength

The earnings mix remains uneven. Cigna Healthcare's adjusted revenue increased 9 percent to 11.7 billion US dollars, and pre-tax adjusted income from operations rose 15 percent to 1.193 billion US dollars. Within Evernorth Health Services, Pharmacy Benefit Services generated 765 million US dollars of adjusted income from operations, down 22 percent year over year, while Specialty and Care Services increased to 1.064 billion US dollars.

The third-quarter release also showed reported shareholders' net income of 1.442 billion US dollars, or 5.47 US dollars per share, compared with 1.868 billion US dollars, or 6.98 US dollars, a year earlier. The comparison was affected by the absence of an after-tax gain on a business sale recognized in the prior-year quarter.

Trading level and investor focus

The Xetra closing figure comes from Yahoo Finance historical prices. Investors are likely to weigh the stronger health-benefits performance against pharmacy contract renewals, investment spending and medical-cost trends.

The Cigna Group stock facts

  • Company: The Cigna Group
  • ISIN: US1255231003
  • Ticker: CI
  • Primary exchange: New York Stock Exchange
  • Lang & Schwarz price: 269.70 euros at 15:35 CET on Tuesday, November 17, 2026
  • Xetra close: 272.00 euros on Monday, November 16, 2026

US equities remain the broader market setting for the shares; see Current market reports.

More news and analyses on The Cigna Group stock.

Disclaimer...
en | US1255231003 | CIGNA GROUP | boerse | 70527442 | bgmi